Resveratrol in the prevention and treatment of coronary artery disease (Q37922623)

25 August 2017

1 reference

title

Resveratrol in the prevention and treatment of coronary artery disease (English)

1 reference

25 August 2017

Louis M Chu

1

1 reference

25 August 2017

Antonio D Lassaletta

series ordinal

2

1 reference

25 August 2017

Michael P Robich

series ordinal

3

1 reference

25 August 2017

Frank W Sellke

series ordinal

4

1 reference

25 August 2017

1 December 2011

1 reference

Current Atherosclerosis Reports

25 August 2017

1 reference

25 August 2017

13

1 reference

25 August 2017

6

1 reference

25 August 2017

439-446

1 reference

https://scigraph.springernature.com/pub.10.1007/s11883-011-0202-3

25 August 2017

0 references

cites work

Heart disease and stroke statistics--2011 update: a report from the American Heart Association

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0202-3

Resveratrol in cardiovascular health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0202-3

Wine, alcohol, platelets, and the French paradox for coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0202-3

Alcohol consumption and risk of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0202-3

Change in alcohol consumption and risk of death from all causes and from ischaemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0202-3

The cardiovascular implications of alcohol and red wine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0202-3

Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0202-3

Long-term effects of resveratrol supplementation on suppression of atherogenic lesion formation and cholesterol synthesis in apo E-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0202-3

Resveratrol toxicity: effects on risk factors for atherosclerosis and hepatic oxidative stress in standard and high-fat diets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0202-3

Resveratrol improves myocardial perfusion in a swine model of hypercholesterolemia and chronic myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0202-3

Resveratrol attenuates the expression of HMG-CoA reductase mRNA in hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0202-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0202-3

Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0202-3

Dynamics of reverse cholesterol transport: protection against atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0202-3

A new insight into resveratrol as an atheroprotective compound: inhibition of lipid peroxidation and enhancement of cholesterol efflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0202-3

Upregulation of endogenous antioxidants and phase 2 enzymes by the red wine polyphenol, resveratrol in cultured aortic smooth muscle cells leads to cytoprotection against oxidative and electrophilic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0202-3

Inhibitory effect of resveratrol on interleukin 6 release by stimulated peritoneal macrophages of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0202-3

Resveratrol inhibits foam cell formation via NADPH oxidase 1- mediated reactive oxygen species and monocyte chemotactic protein-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0202-3

Resveratrol blocks interleukin-18-EMMPRIN cross-regulation and smooth muscle cell migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0202-3

Resveratrol inhibits rat aortic vascular smooth muscle cell proliferation via estrogen receptor dependent nitric oxide production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0202-3

Resveratrol inhibits AGEs-induced proliferation and collagen synthesis activity in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0202-3

SIRT1 inhibits angiotensin II-induced vascular smooth muscle cell hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0202-3

Anti-inflammatory compound resveratrol suppresses homocysteine formation in stimulated human peripheral blood mononuclear cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0202-3

Effect of resveratrol, a natural polyphenolic compound, on platelet activation induced by endotoxin or thrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0202-3

Inhibitory effects of resveratrol on platelet activation induced by thromboxane a(2) receptor agonist in human platelets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0202-3

Mechanisms of resveratrol-induced platelet apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0202-3

Resveratrol inhibits fatty acid and triacylglycerol synthesis in rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0202-3

Resveratrol exerts anti-obesity effects via mechanisms involving down-regulation of adipogenic and inflammatory processes in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0202-3

Resveratrol suppresses body mass gain in a seasonal non-human primate model of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0202-3

SIRT1 takes a backseat to AMPK in the regulation of insulin sensitivity by resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0202-3

Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0202-3

Resveratrol and small artery compliance and remodeling in the spontaneously hypertensive rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0202-3

Restoration of altered microRNA expression in the ischemic heart with resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0202-3

Resveratrol protects myocardial ischemia-reperfusion injury through both NO-dependent and NO-independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0202-3

Resveratrol modifies risk factors for coronary artery disease in swine with metabolic syndrome and myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0202-3

Clinical trials of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0202-3

Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0202-3

Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0202-3

Blood Pressure in Adulthood and Life Expectancy With Cardiovascular Disease in Men and Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0202-3

Resveratrol down-regulates interferon-γ-inducible inflammatory genes in macrophages: molecular mechanism via decreased STAT-1 activation

21 January 2018

1 reference

12 December 2020

Death in the United States, 2007

1 reference

12 December 2020

Resveratrol promotes atherosclerosis in hypercholesterolemic rabbits

1 reference

12 December 2020

Coronary heart disease mortality and alcohol consumption in Framingham

1 reference

12 December 2020

Functional, cellular, and molecular characterization of the angiogenic response to chronic myocardial ischemia in diabetes

1 reference

12 December 2020

Dealcoholized red wine containing known amounts of resveratrol suppresses atherosclerosis in hypercholesterolemic rabbits without affecting plasma lipid levels.

1 reference

12 December 2020

Inhibition of TNF-α-mediated endothelial cell-monocyte cell adhesion and adhesion molecules expression by the resveratrol derivative, trans-3,5,4'-trimethoxystilbene

1 reference

12 December 2020

Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction

1 reference

12 December 2020

Type of alcohol consumed and mortality from all causes, coronary heart disease, and cancer

1 reference

12 December 2020

Type of alcoholic drink and risk of major coronary heart disease events and all-cause mortality

1 reference

12 December 2020

Moderate alcohol and decreased cardiovascular mortality in an elderly cohort

1 reference

12 December 2020

10.1007/S11883-011-0202-3

Identifiers

DOI

1 reference

25 August 2017

1 reference